Saturday September 21, 2019

DNA Changes May Trigger Cancer Along with Other Age-related Diseases

Experts say they will now explore the link between these DNA changes and biological ageing acceleration

0
//
Scientists have found a way of mapping out human DNA.
Scientists have found a way of mapping out human DNA.
DNA changes throughout a person’s life can significantly increase their susceptibility to heart conditions and other age-related diseases, says a research led by an Indian-origin scientist.
Such alterations — known as somatic mutations — can impact the way blood stem cells work and are associated with blood cancers and other conditions, said scientists from the Universities of Edinburgh and Glasgow.
These somatic mutations and the associated diseases they cause may accelerate a person’s biological age — how old their body appears — faster than their chronological age.
“Previously, somatic mutations have largely been studied in cancer. Our findings suggest they play a role in other diseases, which will change the way we study disease risk,” said Dr Tamir Chandra, Group Leader at the University of Edinburgh’s MRC Human Genetics Unit.
The study, published in the journal Current Biology, examined these changes and their potential effects in more than 1,000 older people from the Lothian Birth Cohorts (LBCs), born in 1921 and 1936.
Cancer
Cancer Ribbon. Pixabay
The LBCs are a group of people – now in their 80s and 90s – who sat intelligence tests as 11-year olds. They are some of the most-intensively studied research participants in the world.
Scientists studied people where the biological and chronological age was separated by a large gap.
They found the participants with somatic mutations – around six per cent – had a biological age almost four years older than those with no alterations.
Experts say they will now explore the link between these DNA changes and biological ageing acceleration. (IANS)

Next Story

Tiny Bubbles In Body Better Than Chemotherapy, Research Suggests

Researchers have found that tiny bubbles in our body might potentially be used to treat cancer and could fight the disease better than chemotherapy

0
Cancer, Treatment, Chemotherapy, Tiny Bubbles, Research
"What we've done is improve a therapeutic approach to delivering enzyme-producing genes that can convert certain drugs into toxic agents and target tumours." Pixabay

Researchers have found that tiny bubbles in our body might potentially be used to treat cancer and could fight the disease better than chemotherapy.

Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It’s your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.

According to the researchers, these bubbly extracellular vesicles (EV) could become mini treatment transporters, carrying a combination of therapeutic drugs and genes that target cancer cells and kill them.

The study, published in the journal Molecular Cancer Therapeutics, focused on breast cancer cells in mice.

“What we’ve done is improve a therapeutic approach to delivering enzyme-producing genes that can convert certain drugs into toxic agents and target tumours,” said the study’s lead author Masamitsu Kanada, Assistant Professor at the Michigan State University.

Cancer, Chemotherapy, Tiny Bubbles, Research, Treatment
A Caucasian female nurse smiles as she administers chemotherapy through a catheter to an African American male patient in a clinical setting. Wikimedia Commons

These drugs or prodrugs start out as inactive compounds. But once they metabolize in the body, they are immediately activated and can get to work on fighting everything from cancer to headaches.

Aspirin is an example of a common prodrug.

In this case, researchers used EVs, to deliver the enzyme-producing genes that could activate a prodrug combination therapy of ganciclovir and CB1954 in breast cancer cells.

Minicircle DNA and regular plasmid – two different gene vectors that act as additional delivery mechanisms for DNA – were loaded into the vesicles to see which was better at helping transport treatment.

This is known as a gene-directed enzyme, prodrug therapy.

ALSO READ: Here’s How Poverty Linked with the Ageing Process

They found that the minicircle DNA was 14 times more effective at delivery and even more successful at killing cancerous tumours.

“Conventional chemotherapy isn’t able to differentiate between tumours and normal tissue, so it attacks it all,” Kanada said.

With EVs, treatment can be targeted and because of their compatibility with the human body, this type of delivery could minimize the risk of unwanted immune responses that can come with other gene therapies.

“If EVs prove to be effective in humans, it would be an ideal platform for gene delivery and it could be used in humans sooner than we expect,” Kanada added. (IANS)